ARTA
LJPC

A.R.T. Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

A.R.T. Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,785
Closed -$46K – 324
2020
Q2 		$46K Buy
+10,785
New +$65.7K 0.07% 229
2020
Q1 		– Sell
-130,241
Closed -$512K – 1297
2019
Q4 		$512K Buy
130,241
+81,900
+169% +$484K 0.03% 845
2019
Q3 		$425K Buy
+48,341
New +$457K 0.02% 918
2019
Q2 		– Sell
-131,210
Closed -$844K – 1823
2019
Q1 		$844K Buy
+131,210
New +$855K 0.05% 544
2015
Q2 		– Sell
-19,557
Closed -$357K – 1957
2015
Q1 		$357K Buy
+19,557
New +$396K 0.01% 1049
2014
Q4 		– Sell
-14,678
Closed -$141K – 1936
2014
Q3 		$141K Buy
+14,678
New +$146K 0.01% 1167

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

A.R.T. Advisors's LJPC Position: Q3 2020 in Review

A.R.T. Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 10,785 shares — an estimated $46K sold.

A.R.T. Advisors first reported a position in LJPC in Q3 2014 and held it in 6 quarters. The position peaked at $844K in Q1 2019. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • A.R.T. Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 10,785 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $46K.
  • A.R.T. Advisors first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 6 quarters.
  • A.R.T. Advisors's La Jolla Pharmaceutical Company position peaked at $844K in Q1 2019.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on A.R.T. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.